QUICKSILVER BIOSCIENCES, INC.
Medtech · Private
Single-molecule field-effect transistor (smFET) array on CMOS chip for direct bioelectronic detection of viral proteins from saliva
quicksilverbiosciences.com →- Grants
- $2.2M
- 5 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20182019202020212022
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | National Science Foundation · Phase I · SBIR Phase I: Single-molecule field-effect transistor arrays for multiplexed genomic identification of infectious diseases | $225,000 | |
| Federal grant | National Science Foundation · Phase I · SBIR Phase I: Rapid COVID-19 diagnostics with CMOS-integrated single-molecule field-effect transistors | $255,678 | |
| Federal grant | Department of Health and Human Services · Phase II · Direct bioelectronic detection of SARS-CoV-2 from saliva using single-molecule field-effect transistor array | $817,335 | |
| Federal grant | Department of Health and Human Services · Phase II · Direct bioelectronic detection of SARS-CoV-2 from saliva using single-molecule field-effect transistor array | $447,801 | |
| Federal grant | Department of Health and Human Services · Phase II · Direct bioelectronic detection of SARS-CoV-2 from saliva using single-molecule field-effect transistor array | $447,801 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1268 | Lento Bio, Inc | — | $5.0M |
| 1269 | MIMETAS US, INC | — | — |
| 1270 | Whisker Labs, Inc. | — | $11M |
| 1271 | QUICKSILVER BIOSCIENCES, INC. | — | — |
| 1272 | RD RESEARCH TECHNOLOGY USA LLC | — | — |
| 1273 | Cardiio, Inc. | — | — |
| 1274 | HYPERMELT, LLC | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.